Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL2100036	注射用Luspatercept	luspatercept	Lyophilized	Biological Products(2.2)	Import Drug Application	2021-03-05	新基医药咨询（上海）有限公司	Xinji Pharmaceutical Consulting (Shanghai) Co Ltd	In Review	2021-03-05	view
JXSL2100035	注射用Luspatercept	luspatercept	Lyophilized	Biological Products(2.2)	Import Drug Application	2021-03-05	新基医药咨询（上海）有限公司	Xinji Pharmaceutical Consulting (Shanghai) Co Ltd	In Review	2021-03-05	view
JXSL2000207	注射用Luspatercept	luspatercept	Lyophilized	Biological Products(3.1)	Import Drug Application	2020-12-02	新基医药咨询（上海）有限公司	Xinji Pharmaceutical Consulting (Shanghai) Co Ltd	In Review	2020-12-01	view
JXSL2000208	注射用Luspatercept	luspatercept	Lyophilized	Biological Products(3.1)	Import Drug Application	2020-12-02	新基医药咨询（上海）有限公司	Xinji Pharmaceutical Consulting (Shanghai) Co Ltd	In Review	2020-12-01	view